Fig. 1From: The Alzheimer’s disease drug development landscapeAD drugs in development, preclinical vs clinical. The number of drugs per target class in preclinical development is shown as a percentage of all drugs in preclinical development, and the number of drugs per target class in clinical development is shown as a percentage of all drugs in clinical developmentBack to article page